Nutex Health Inc. (NUTX)
| Market Cap | 1.29B +149.6% |
| Revenue (ttm) | 846.72M +6.9% |
| Net Income | 179.92M +219.3% |
| EPS | 25.24 +172.8% |
| Shares Out | 6.85M |
| PE Ratio | 7.46 |
| Forward PE | 7.01 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 50,066 |
| Open | 185.01 |
| Previous Close | 188.41 |
| Day's Range | 185.00 - 192.20 |
| 52-Week Range | 77.21 - 204.00 |
| Beta | 1.99 |
| Analysts | Strong Buy |
| Price Target | 266.40 (+41.63%) |
| Earnings Date | Aug 6, 2026 |
About NUTX
Nutex Health Inc. operates as a healthcare services and operations company in the United States. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The Hospital segment develops and operates a network of micro hospitals, specialty hospitals, and hospital outpatient departments that offer healthcare services, including emergency room care, inpatient care, and behavioural health. It also provides imaging services, such as CT scan, X-ray, MRI, ultrasound, etc.; laboratory services; and onsite inpatie... [Read more]
Financial Performance
In 2025, Nutex Health's revenue was $875.26 million, an increase of 82.36% compared to the previous year's $479.95 million. Earnings were $70.79 million, an increase of 35.88%.
Financial StatementsAnalyst Summary
According to 5 analysts, the average rating for NUTX stock is "Strong Buy." The 12-month stock price target is $266.4, which is an increase of 41.63% from the latest price.
News
NUTEX HEALTH OPENS WEST LITTLE ROCK EMERGENCY HOSPITAL IN ARKANSAS
HOUSTON, Aug. 18, 2026 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 28 state-of-the-art micro...
Nutex Health price target raised to $310 from $235 at Lake Street
Lake Street analyst Ben Haynor raised the firm’s price target on Nutex Health (NUTX) to $310 from $235 and keeps a Buy rating on the shares. Q2’s profitability headline was…
Nutex Health management to meet with Freedom Capital
Meeting to be held in Denver on August 11 and in Portland, Oregon on August 12 hosted by Freedom Capital.
Nutex Health Earnings Call Transcript: Q2 2026
Q2 2026 saw strong patient volume growth and a sharp rise in profitability, despite lower revenue due to prior IDR catch-up effects. Regulatory and vendor changes reduced arbitration costs, while new hospital openings and service line expansions support long-term growth.
Nutex Health Quarterly report: Q2 2026
Nutex Health has published its Q2 2026 quarterly earnings report on August 7, 2026.
Nutex Health Earnings release: Q2 2026
Nutex Health released its Q2 2026 earnings on August 7, 2026, summarizing the period's financial results.
NUTEX HEALTH REPORTS SECOND QUARTER 2026 FINANCIAL RESULTS
HOUSTON, Aug. 6, 2026 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), today announced financial results for the three and six months ended June 30, 2026. Nutex Heal...
Nutex Health Schedules 2026 Second Quarter Financial Results Release and Conference Call
HOUSTON, July 21, 2026 /PRNewswire/ — Nutex Health, Inc. (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 27 state-of-the-art micro hospitals and hospital outpatient...
Nutex Health initiated with a Buy at B. Riley
B. Riley analyst Anderson Schock initiated coverage of Nutex Health (NUTX) with a Buy rating and $290 price target Nutex Health operates a network of micro-hospitals serving the gap between…
Nutex Health initiated with a Buy at B. Riley
B. Riley initiated coverage of Nutex Health (NUTX) with a Buy rating and $290 price target
Nutex Health initiated with a Buy at Lake Street
Lake Street analyst Ben Haynor initiated coverage of Nutex Health (NUTX) with a Buy rating and $235 price target Shares of micro-hospital operator trade at a “mere ~3x EV/EBITDA,” notes…
Nutex Health Slides: Corporate presentation
Nutex Health has posted slides in relation to its latest quarterly earnings report, which was published on May 4, 2026.
Nutex Health Earnings Call Transcript: Q1 2026
Revenue and net income grew year-over-year, while adjusted EBITDA declined due to arbitration cost timing. Cash flow and liquidity remain strong, with new hospital openings and direct development initiatives supporting future growth. Legislative and payer dynamics continue to influence reimbursement.
Nutex Health Earnings release: Q1 2026
Nutex Health released its Q1 2026 earnings on May 1, 2026, summarizing the period's financial results.
Nutex Health Quarterly report: Q1 2026
Nutex Health has published its Q1 2026 quarterly earnings report on May 1, 2026.
Nutex Health reports Q1 EPS $6.52 vs. $3.33 last year
Reports Q1 revenue $216.49M, consensus $227.8M. “The 2026 year has started out strong producing solid revenue of $216.5 million, net income attributable to Nutex of $46.8 million, diluted EPS of…
NUTEX HEALTH REPORTS FIRST QUARTER 2026 FINANCIAL RESULTS
HOUSTON, April 30, 2026 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), today announced financial results for the three months ended March 31, 2026. Nutex Health is...
Nutex Health Transcript: AGM 2026
The meeting covered director elections, executive compensation, and auditor ratification, with all proposals approved by the required majority. Voting results will be reported on Form 8-K within four business days.
Nutex Health Schedules 2026 First Quarter Financial Results Release and Conference Call
HOUSTON, April 22, 2026 /PRNewswire/ -- Nutex Health, Inc. (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 27 state-of-the-art micro hospitals and hospital outpatie...
Nutex Health Proxy statement: Proxy Filing
Nutex Health filed a proxy statement on March 13, 2026, providing details for shareholder voting and corporate governance matters.
Nutex Health Proxy statement: Proxy Filing
Nutex Health filed a proxy statement on March 13, 2026, providing details for shareholder voting and corporate governance matters.
Nutex Health Earnings Call Transcript: Q4 2025
Revenue grew 82% to $875.3M in 2025, with net income up to $70.8M and adjusted EBITDA rising 152.6%. Despite a one-time $55M Q4 revenue reduction from arbitration true-up, cash flow and patient volumes remained strong, supporting continued expansion and high patient satisfaction.
Nutex Health Earnings release: Q4 2025
Nutex Health released its Q4 2025 earnings on March 6, 2026, summarizing the period's financial results.
Nutex Health Annual report: Q4 2025
Nutex Health has published its Q4 2025 annual report on March 6, 2026.
Morning Movers: Nutex Health sinks after fourth quarter results
Futures are lower this morning with investors continuing to price the macro and geopolitical shock stemming from the rapidly escalating conflict involving Iran and its implications for global energy s...